Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Low
146.25
High
261.00
Low
213.77
High
224.99
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Hikal Limited stacks up against its Drug Manufacturers - Specialty & Generic peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | HIKAL Hikal Limited | 218.50 | 0.28% | 0.00 | -2.75 | 2,690 | 4.86% | 14.78% | 261.00 / 146.25 |
| 2 | AARTIDRUGS Aarti Drugs Limited | 419.00 | 2.76% | 20.01 | 20.94 | 3,824 | 0.95% | 11.68% | 534.00 / 318.95 |
| 3 | AARTIPHARM Aarti Pharmalabs Limited | 980.00 | 2.75% | 44.50 | 22.02 | 8,854 | 16.95% | 12.68% | 1,002.40 / 585.00 |
| 4 | ABBOTINDIA Abbott India Limited | 26,850.00 | 1.01% | 35.33 | 759.88 | 57,033 | 0.75% | 16.87% | 30,655.00 / 25,135.00 |
| 5 | AHCL ANLON HEALTHCARE LIMITED | 32.86 | 4.97% | 13.55 | 2.42 | 1,746 | 116.33% | 261.10% | 37.24 / 10.37 |
| 6 | AJANTPHARM Ajanta Pharma Limited | 3,586.00 | 0.96% | 39.48 | 90.83 | 44,748 | 0.38% | 46.24% | 3,796.00 / 2,379.30 |
| 7 | AKUMS AKUMS DRUGS AND PHARMA L | 815.80 | 0.33% | 42.83 | 19.05 | 12,490 | 8.48% | 74.32% | 838.80 / 409.30 |
| 8 | ALIVUS Alivus Life Sciences Limited | 1,380.00 | 0.05% | 28.15 | 49.03 | 16,942 | 2.62% | 46.19% | 1,493.80 / 819.00 |
| 9 | ALKEM Alkem Laboratories Limited | 5,215.00 | 1.00% | 28.90 | 180.45 | 62,353 | 2.85% | 2.00% | 5,933.50 / 5,051.00 |
| 10 | AMRUTANJAN Amrutanjan Health Care Limited | 516.00 | 0.24% | 27.63 | 18.67 | 1,483 | 1.71% | 28.74% | 760.15 / 476.50 |
| 11 | APLLTD Alembic Pharmaceuticals Limited | 819.00 | 0.78% | 23.22 | 35.27 | 16,099 | 1.72% | 13.12% | 998.00 / 635.80 |
| 12 | ASTRAZEN AstraZeneca Pharma India Limited | 6,010.00 | 2.85% | 88.58 | 67.85 | 15,078 | 16.41% | 31.32% | 9,849.50 / 5,986.00 |
| 13 | AUROPHARMA Aurobindo Pharma Limited | 1,666.30 | 0.34% | 26.03 | 64.00 | 96,479 | 2.86% | 62.15% | 1,740.00 / 1,066.80 |